In a previous study using a MC38 murine tumor model, an elevated PD-L2 expression level was seen in TAMs treated with anti-PD-L1 antibody, and anti-PD-L2 antibody enhanced the anti-tumor immune responses induced by the anti-PD-L1 antibody26. This evidence concerns the gene CD274 and neoplasm.